Diagnostic accuracy of serum miR-23a-3p, miR-150, and miR-150-5p for diabetic osteoporosis in adults with type 2 diabetes: a retrospective single-center cohort study

血清 miR-23a-3p、miR-150 和 miR-150-5p 对 2 型糖尿病成人糖尿病性骨质疏松症的诊断准确性:一项回顾性单中心队列研究

阅读:1

Abstract

BACKGROUND: Diabetic osteoporosis (DOP) is a frequently under-recognized complication of type 2 diabetes (T2D). This study evaluated the association and diagnostic performance of serum miR-23a-3p, miR-150, and miR-150-5p for identifying DOP in adults with T2D. METHODS: A single-center retrospective cohort included 225 adults with T2D (DOP, n = 57; non-DOP, n = 168). Serum microRNAs were quantified by qRT-PCR. Independent associations with DOP were assessed using multivariable logistic regression. Discrimination was evaluated by ROC analysis for each miRNA and a combined model, and calibration was examined. RESULTS: Compared with the non-DOP group, the DOP group was older, had a longer diabetes duration, and had higher fasting plasma glucose and HbA1c (all P < 0.05). Serum miR-23a-3p, miR-150, and miR-150-5p levels were higher in DOP (all P < 0.001) and remained independently associated with DOP (miR-23a-3p: OR 3.71; miR-150: OR 5.32; miR-150-5p: OR 9.57). The AUCs were 0.77 (miR-23a-3p), 0.88 (miR-150), and 0.80 (miR-150-5p). The combined model achieved an AUC of 0.95 with 0.95 sensitivity and 0.82 specificity, with good calibration. CONCLUSIONS: Serum miR-23a-3p, miR-150, and miR-150-5p were independently associated with DOP, and their combined assessment showed excellent diagnostic discrimination. External validation and analytical standardization are required before this panel can be considered for clinical application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。